This study is a two-arm randomized controlled trial in which participants will receive either the Livongo Health system or iHealth glucose meter for measuring their blood glucose. The study hypothesizes the use of the Livongo Health system results in a greater improvement in A1c compared to standard blood glucose monitoring, as demonstrated by the iHealth Bluetooth-enabled glucose meter.
Study of Unprecedented Glucose Analysis and Results: A Randomized Controlled Trial of the Effect of the Livongo Health Diabetes Management Program vs. Standard Care on Glycemic Control
Participants in this study will partake in study surveys, daily blood glucose monitor measurements, and blood sampling for the duration of their participation. The study intends to recruit and randomize 200 participants.
You can join if…
Open to people ages 18 years and up
People with type 1 or 2 diabetes mellitus on any type of medication
Adults, age 18 years or older
Not using continuous glucose monitoring or an insulin pump
iOS Smartphone with access to data and/or Wi-Fi
You CAN'T join if...
Using continuous glucose monitoring during the study period
Using an insulin pump during the study period
Unable or unwilling to switch blood glucose meters to the study meter
Hospitalization for DKA or hypoglycemia in the past 1 month prior to enrollment
Pregnant patients, or intention to become pregnant during the study period
University of California, San Francisconot yet accepting patients San Francisco, California, 94158, United States